Each film-coated tablet contains:
Favipiravir 200 mg
FAVIBLU Tablets are indicated for the treatment of patients with mild to moderate corona virus disease 2019 (COVID-19). Favipiravir has been approved in India for restricted emergency use in light of COVID-19 outbreak.
DOSAGE AND ADMINISTRATION
For Oral Administration in Adults:Favipiravir 1800 mg twice daily on day 1 as a loading dose (9 tablets BID), followed by 800 mg twice daily (4 tablets BID) as a maintenance dose from day 2 onwards for up to maximum 14 days. The administration should be started immediately after the onset of COVID-19 symptoms.
Or, as prescribed by the physician.
10 Tablets per strip.